The developer assessed the possibility of revaccination with EpiVacCorona

The EpiVacCorona CORONAVIRUS vaccine developed by the Vector Center can be used for revaccination an unlimited number of times. This was reported by the press service of Rospotrebnadzor with reference to the scientific center, RIA Novosti reports.

“The composition of the EpiVacCoron vaccine makes it possible to use it for revaccination – without limiting their number,” they said.

They also clarified that such revaccination is safe and is designed to increase immunity to covid-19 to values ​​​​at which permanent protection is provided.

"Vector" announced the effectiveness of "EpiVakKorona" against strains of covid Society

On June 21, Russian Minister of HEALTH Mikhail Murashko announced that the Ministry of Health had developed special recommendations for revaccinating the population against coronavirus. “So far, we see that during the period of the epidemic rise, this will need to be done in six months, both for those who have been ill and those who have been vaccinated earlier,” he said. Press Secretary of the President of RUSSIA Dmitry Peskov also stated that revaccination in Russia is inevitable.

As Moscow Mayor Sergei Sobyanin explained, re-vaccination against coronavirus will be carried out with the first component of the vaccine that a person has previously been vaccinated with.

Earlier, the Vector Center reported on the effectiveness of EpiVacCorona against various strains of COVID-19. So, the antibodies produced by the vaccine are able to neutralize the reference strain of coronavirus, as well as its British and South African variants. According to the results of clinical and post-registration studies, there is no reason to doubt the safety of the vaccine and the production of neutralizing antibodies, they added.

Read on RBC Pro Pareto Rule in the profession: how to be successful without any extra effort “Fire quickly!”:Ten army truths from the president of Levi's How Pepsi's marketing mistake turned into a disaster - BLOOMBERG Mysterious $ 50 billion and super dividends: whether to buy Surgutneftegaz shares

EpiVacCorona became the second COVID-19 vaccine registered in Russia. President Vladimir Putin announced its registration in October last year.

June 21, 11:30 Moscow time Coronavirus Russia Moscow World +8361 (per day) 4.9 million Recovered 0 +17378 (per day) 5.3 million Infected 0 +440 (per day) 129.8 thousand Died +3098 ( per day) 1.1 million Recovered 0 +7584 (per day) 1.3 million Infected 0 +79 (per day) 21.5 thousand Died +4297056 (per day) 159.1 million Recovered 0 +290487 (per day) ) 178.4 million Infected 0 +6068 (per day) 3.9 million Died Source: JHU,
federal and regional
virus control headquarters Source: JHU, federal and regional virus control headquarters Read more